Northpond Ventures’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Northpond Ventures’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-546,897	Closed	-$2M	–	4
2024 Q2	$2M	Buy	546,897 +1	+0%	+$5	3.61%	4
2024 Q1	$4.33M	Hold	546,896	–	–	4.22%	3
2023 Q4	$3.93M	Hold	546,896	–	–	18.69%	2
2023 Q3	$10.2M	Hold	546,896	–	–	29.47%	2
2023 Q2	$15.6M	Hold	546,896	–	–	25.82%	2
2023 Q1	$30.5M	Hold	546,896	–	–	17.44%	3
2022 Q4	$11.8M	Hold	546,896	–	–	6.41%	4
2022 Q3	$16.3M	Hold	546,896	–	–	11.45%	3
2022 Q2	$17.7M	Hold	546,896	–	–	16.88%	3
2022 Q1	$52.9M	Hold	546,896	–	–	28.49%	2
2021 Q4	$106M	Buy	+546,896	New	+$85.1M	37.21%	1

Other funds holding TBIO

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Northpond Ventures's TBIO Position: Q3 2024 in Review

Northpond Ventures sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q3 2024, closing a stake of 546,897 shares — an estimated $2M sold.

Northpond Ventures first reported a position in TBIO in Q4 2021 and held it in 11 quarters. The position peaked at $106M in Q4 2021. 1 fund tracked by Wall St. Rank holds TBIO as of Q3 2024.

Northpond Ventures reported no remaining Telesis Bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Northpond Ventures sold 546,897 Telesis Bio, Inc. Common Stock shares in Q3 2024, an estimated $2M.
Northpond Ventures first reported a position in Telesis Bio, Inc. Common Stock in Q4 2021 and held it in 11 quarters.
Northpond Ventures's Telesis Bio, Inc. Common Stock position peaked at $106M in Q4 2021.
1 fund tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q3 2024.

Based on Northpond Ventures's 13F filing for Q3 2024, filed 14 Nov 2024.